Results for tag: "Votubia"

The Votubia market is a subset of the oncology drug market, focusing on the treatment of tumors. It is composed of drugs that target the vascular endothelial growth factor (VEGF) pathway, which is involved in the growth and spread of cancer cells. These drugs are used to treat a variety of cancers, including colorectal, renal, and non-small cell lung cancer. Votubia is a monoclonal antibody that binds to VEGF and prevents it from binding to its receptor, thus inhibiting tumor growth. The Votubia market is highly competitive, with several major pharmaceutical companies offering their own versions of the drug. These include Roche, Novartis, Pfizer, and AstraZeneca. Other companies, such as Amgen and Merck, are also developing their own VEGF-targeting drugs. These drugs are expected to become increasingly important in the treatment of cancer in the coming years. Show Less Read more